![Table 1 from Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. | Semantic Scholar Table 1 from Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/da540c7125123768b0eeab52201790372885ddba/2-Table1-1.png)
Table 1 from Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. | Semantic Scholar
![The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006322319313794-gr1.jpg)
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect
![κ‑opioid receptor agonist U50488H attenuates postoperative cognitive dysfunction of cardiopulmonary bypass rats through the PI3K/AKT/Nrf2/HO‑1 pathway κ‑opioid receptor agonist U50488H attenuates postoperative cognitive dysfunction of cardiopulmonary bypass rats through the PI3K/AKT/Nrf2/HO‑1 pathway](https://www.spandidos-publications.com/article_images/mmr/23/4/mmr-23-04-11933-g05.jpg)
κ‑opioid receptor agonist U50488H attenuates postoperative cognitive dysfunction of cardiopulmonary bypass rats through the PI3K/AKT/Nrf2/HO‑1 pathway
![IJMS | Free Full-Text | Mechanism Governing Human Kappa-Opioid Receptor Expression under Desferrioxamine-Induced Hypoxic Mimic Condition in Neuronal NMB Cells IJMS | Free Full-Text | Mechanism Governing Human Kappa-Opioid Receptor Expression under Desferrioxamine-Induced Hypoxic Mimic Condition in Neuronal NMB Cells](https://www.mdpi.com/ijms/ijms-18-00211/article_deploy/html/images/ijms-18-00211-g001.png)
IJMS | Free Full-Text | Mechanism Governing Human Kappa-Opioid Receptor Expression under Desferrioxamine-Induced Hypoxic Mimic Condition in Neuronal NMB Cells
![Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor - ScienceDirect Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0898656817300165-fx1.jpg)
Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor - ScienceDirect
![From Pharmacology to Physiology: Endocrine Functions of μ-Opioid Receptor Networks: Trends in Endocrinology & Metabolism From Pharmacology to Physiology: Endocrine Functions of μ-Opioid Receptor Networks: Trends in Endocrinology & Metabolism](https://www.cell.com/cms/attachment/4e7c3bc5-3c9a-4ec1-9845-4f13f11142da/gr1_lrg.jpg)
From Pharmacology to Physiology: Endocrine Functions of μ-Opioid Receptor Networks: Trends in Endocrinology & Metabolism
![Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor | Journal of Neuroinflammation | Full Text Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor | Journal of Neuroinflammation | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12974-018-1087-7/MediaObjects/12974_2018_1087_Fig9_HTML.gif)
Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor | Journal of Neuroinflammation | Full Text
![Summary of the neuroprotective and deleterious affects of dynorphin A... | Download Scientific Diagram Summary of the neuroprotective and deleterious affects of dynorphin A... | Download Scientific Diagram](https://www.researchgate.net/publication/8153992/figure/fig2/AS:277696144789525@1443219328903/Summary-of-the-neuroprotective-and-deleterious-affects-of-dynorphin-A-1-17-in.png)
Summary of the neuroprotective and deleterious affects of dynorphin A... | Download Scientific Diagram
![Frontiers | Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective Frontiers | Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective](https://www.frontiersin.org/files/Articles/551365/fphar-11-01078-HTML/image_m/fphar-11-01078-g001.jpg)
Frontiers | Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective
![Spirocyclic Delta Opioid Receptor Agonists for the Treatment of Pain: Discovery of N,N-Diethyl-3-hydroxy-4-(spiro[chromene-2,4′-piperidine]-4-yl) Benzamide (ADL5747) | Journal of Medicinal Chemistry Spirocyclic Delta Opioid Receptor Agonists for the Treatment of Pain: Discovery of N,N-Diethyl-3-hydroxy-4-(spiro[chromene-2,4′-piperidine]-4-yl) Benzamide (ADL5747) | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm900773n/asset/images/large/jm-2009-00773n_0011.jpeg)
Spirocyclic Delta Opioid Receptor Agonists for the Treatment of Pain: Discovery of N,N-Diethyl-3-hydroxy-4-(spiro[chromene-2,4′-piperidine]-4-yl) Benzamide (ADL5747) | Journal of Medicinal Chemistry
![Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment - ScienceDirect Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0278584615000020-gr1.jpg)
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment - ScienceDirect
![Prolonged Opportunity for Ischemic Neuroprotection with Selective κ-Opioid Receptor Agonist in Rats | Stroke Prolonged Opportunity for Ischemic Neuroprotection with Selective κ-Opioid Receptor Agonist in Rats | Stroke](https://www.ahajournals.org/cms/asset/631e3cea-8cb6-4dc9-9bfe-948be2ecc464/33ff1.jpeg)
Prolonged Opportunity for Ischemic Neuroprotection with Selective κ-Opioid Receptor Agonist in Rats | Stroke
![The binding of dynorphin-13 to κ-opioid and NMDA receptors. Dynorphin A... | Download Scientific Diagram The binding of dynorphin-13 to κ-opioid and NMDA receptors. Dynorphin A... | Download Scientific Diagram](https://www.researchgate.net/profile/Amin-Tashakor-2/publication/349239377/figure/fig1/AS:992778490236929@1613708245173/The-binding-of-dynorphin-13-to-k-opioid-and-NMDA-receptors-Dynorphin-A-1-13-binds-to_Q320.jpg)
The binding of dynorphin-13 to κ-opioid and NMDA receptors. Dynorphin A... | Download Scientific Diagram
![Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects](https://www.mdpi.com/molecules/molecules-28-00346/article_deploy/html/images/molecules-28-00346-g001.png)
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
![Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects](https://www.mdpi.com/molecules/molecules-28-00346/article_deploy/html/images/molecules-28-00346-g007.png)